The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

The researchers found that Fasenra can be more effective than the oral corticosteroid prednisolone when injected during an ...

AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...

THE first new treatment for asthma attacks in 50 years has been developed and could be “game-changing” for millions of people ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

A study highlights the effectiveness of AstraZeneca's Fasenra, an injectable treatment for severe asthma, outperforming oral steroids during attacks by reducing further treatment needs by 30%.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...